Seaport Therapeutics to Present at Two Key Healthcare Conferences
Event summary
- Seaport Therapeutics will participate in Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026, at 8:00 AM EDT.
- The company will also present at UBS Virtual CNS Day on June 15, 2026, at 10:00 AM EDT.
- Live webcasts and archived replays will be available on Seaport Therapeutics' investor relations website.
- Seaport will engage in one-on-one meetings with investors at both conferences.
The big picture
Seaport Therapeutics' participation in high-profile investor conferences underscores its focus on engaging with the investment community amid a competitive landscape in neuropsychiatric drug development. The company's differentiated approach using its GlyphTM platform aims to address unmet needs in depression, anxiety, and other neuropsychiatric disorders, positioning it for potential strategic partnerships or funding opportunities.
What we're watching
- Investor Sentiment
- How Seaport Therapeutics' presentations will impact investor perception of its neuropsychiatric drug pipeline.
- Pipeline Updates
- Whether the company will provide new insights into its GlyphTM platform or clinical-stage programs.
- Competitive Positioning
- The pace at which Seaport Therapeutics can differentiate itself in the crowded neuropsychiatric therapeutics market.
Related topics